News
- Grand Rapids
- Kent County
- Kzoo and BC
- Musk County
- Ottawa County
- Allegan County
- Local and Mich
- National
- News Links
- Crime
- Strange
- Target 8
Weather
- Alerts
- Beaches
- Bills Blog
- Closings
- Currents
- Forecasts
- Radar
- Satellite
- SatRad
- Severe
- Webcams
Traffic
Sports
- MLB
- NBA
- NCAA Bball
- NCAA Football
- NFL
- NHL
- Scores
- Auto Racing
onPolitix
- To The Point
- Politics
Video
- Live Video
- Your Videos
- Entertainment
- Grand Rapids
- Kent County
- Latest
- National
- NBC
- Strange
Your Money
Entertainment
- Blogs
- Celebrities
- Movies
- Music
- Must See Video
- Pet of Week
- Photo
- TV Schedule
Report It
Community
- CWC Awards
- Calendar
eightWest
- Ask The Expert
- Contests
- Fab Finds
- Living Well
- My Family
- West Vibe
- Whats West
- Your Home
Local Guides

Home : Health : Healthy Living :

Healthy Living

11 tons of beef recalled

The recall is categorized by the FSIS as "Class I": a health …

The dangers of too many vitamins

Studies have shown that vitamins have been linked to disease …

Can Facebook organ donor success stick?

On the first day of the initiative, there were 13,012 new …

Alternative healing or quackery?

Dr. Paul Offit says some alternative therapists promote …

Skin: Battling the 'Over the Hill' myth

Do you remember that whole line of “Over the Hill” birthday …

NY bio co. gets $4.6M from Russia to develop drugs

Initiative focuses on anti-infection drugs

Updated: Wednesday, 28 Nov 2012, 4:35 PM EST
Published : Wednesday, 28 Nov 2012, 4:35 PM EST

The Associated Press

BUFFALO, N.Y. (AP) - A western New York company says it has signed a $4.6 million contract with Russia to develop anti-infection drugs.

Buffalo-based Cleveland BioLabs Inc. says the contract with the Ministry of Industry and Trade of the Russian Federation was issued under the federation's "Pharma 2020" pharmaceutical development initiative.

The contract announced Tuesday focuses on Xenomycins, a family of compounds being developed as potential treatments for infectious diseases. It's being handled through Panacela Labs, a biotechnology startup company that was founded last year as a joint venture between Cleveland BioLabs and a Russian investment company.